Synthetic Genomics: Building Genomes from Scratch and Why It Matters for Medicine
Synthetic genomics builds entire genomes from scratch using engineered DNA. Learn how it works, its medical applications, and what it means for biotech founders.
Organoids as Drug Screening Platforms: Bridging the Gap Between Lab and Clinic
How patient-derived organoids are closing the preclinical-to-clinical gap in drug screening. Strategic insights for biotech founders and translational researchers.
RNA Base Editing Explained: Reversible Gene Correction and Its Therapeutic Promise
Compare RNA and DNA base editing mechanisms, reversibility, and therapeutic applications. Understand which approach fits your gene correction strategy in 2025.
Spatial Transcriptomics in Drug Discovery: From Tissue Maps to Therapeutic Targets
How spatial transcriptomics maps gene expression in tissue to accelerate target identification, MOA studies, and biomarker discovery. Read the strategic breakdown.